Skip to content

Study · Animal study (in vivo) · chicken · 2005

1 result

Avian thymic hormone treatment of peripheral blood mononuclear cells from young chicks stimulates acute graft-versus-host reaction in chicken embryos.

Vásquez GM, Ragland WL

Developmental and comparative immunology13 Jan 2005Cited by 3 (Europe PMC)

PMID15784296 (opens in a new tab)DOI10.1016/j.dci.2004.11.005 (opens in a new tab)PepBankPUB-15784296
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In chicken embryos, PBMC treated in vitro with thymosin alpha‑1 did not produce an enhanced acute graft-versus-host reaction.

    In plain wordsIn chicken embryos, immune cells treated with thymosin alpha‑1 did not make the graft-versus-host reaction stronger.

    Peptide
    Thymosin alpha-1
    Outcome
    No significant changeAcute graft-versus-host reaction
    Study

    chickenn: not reported in source

    Acute graft-versus-host reaction in chicken embryos
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated · in vitro treatment of PBMC for 2 hAs given in this study (chicken).

    Source sentences

    Summary
    Only PBMC treated with TE or ATH produced an enhanced acute GVHR.
    1 context sentence
    Summary · context
    PBMC from 3-day-old chicks were treated in vitro with TE, ATH, thymosin fraction 5 or thymosin alpha1 for 2 h and injected into 14-day-old embryos.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.